No association between the progesterone receptor gene polymorphism (+331G/a) and the risk of breast cancer: An updated meta-analysis

5Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

This artice is free to access.

Abstract

Background: Many published studies have estimated the association between the +331G/A (rs10895068) polymorphism in the progesterone receptor (PgR) gene and breast cancer risk. However, the results remain inconsistent and controversial. To address this inconsistency, we systematically interrogated the aforementioned association via a meta-analysis. Methods: Through a literature search, we identified 13 case-control studies, including 12,453 cases and 14,056 case-free controls. The strengths of reported associations were evaluated using odds ratios (ORs) with 95% confidence intervals (95%CIs). Results: An association was found between +331G/A polymorphism and +331G/A risk in the dominant model (p = 0.027). Via subgroup analysis, we found no association between +331G/A and breast cancer risk in Caucasians, Asians or mixed racial groups. Conclusions: Through meta-analysis, we were able to gain insight into previously reported associations between +331G/A polymorphism and breast cancer risk. However, further studies are still needed to provide more evidence.

Cite

CITATION STYLE

APA

Qi, X. ling, Yao, J., & Zhang, Y. (2017). No association between the progesterone receptor gene polymorphism (+331G/a) and the risk of breast cancer: An updated meta-analysis. BMC Medical Genetics, 18(1). https://doi.org/10.1186/s12881-017-0487-3

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free